Sophomer provides artificial polymers made to replace the bovine serum albumin that is used in immunological tests.
Sophomer has raised $369K in total funding. The most recent round was Seed. The last funding was announced in March 2023.
Sophomer's investors include i&i Prague, i&i Biotech Fund.
Sophomer is headquartered in Prague, Czech Republic.
Sophomer provides artificial polymers made to replace the bovine serum albumin that is used in immunological tests.
Sophomer is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Sophomer — Funding & Investors." VCBacked, March 29, 2023, https://www.vcbacked.co/company/sophomer. Accessed September 30, 2026.
VCBacked. (2023). Sophomer — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/sophomer
{{cite web |title=Sophomer — Funding & Investors |url=https://www.vcbacked.co/company/sophomer |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated